Ameed Bawwab
Research Subjects
Ameed Bawwab has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Aaron T. Gerds
Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
2 shared publications - Abhay Singh
Taussig Cancer Center, Cleveland Clinic
2 shared publications - Ahmed Nabil Mohamed
Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
2 shared publications Akriti G. Jain
2 shared publications- Anjali S. Advani
Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2 shared publications Asad Rauf
2 shared publications
Latest Publications
- Open Access
- 12 August 2026
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 26 (10) , e1160-e1174
The Prognostic Utility of Normal Karyotype Fraction in Acute Myeloid Leukemia
- 12 August 2026
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 26 (10) , e1160-e1174
Open AccessThe Prognostic Utility of Normal Karyotype Fraction in Acute Myeloid Leukemia
- Open Access
- 19 June 2026
- Published by Elsevier in SSRN Electronic Journal
The Prognostic Utility of Normal Karyotype Fraction in Acute Myeloid Leukemia
Background: The prognostic significance of the proportion of normal metaphases detected at diagnosis in acute myeloid leukemia (AML) has not been systematically evaluated. Methods: We conducted a retrospective cohort study of 893 adult AML patients treated at Cleveland Clinic between 01/2015-09/2023 who underwent conventional cytogenetic analysis. Normal karyotype fraction (NKF) was defined as the proportion of normal metaphases among all metaphases analyzed at diagnosis. NKF was evaluated as a continuous measure and categorized using three-group (NKF = 0, 0 < NKF < 1, NKF = 1) and five-group functional classification systems. Primary outcomes included overall survival (OS), event-free survival (EFS), composite complete remission (CR/CRi), and relapse. Multivariable Cox proportional hazards and logistic regression models were adjusted for established prognostic covariates. Results: NKF demonstrated a bimodal distribution across the cohort. Patients with NKF = 1 achieved the highest CR/CRi rate (64%) and longest median OS (16 months) and EFS (11 months). In multivariable analyses, NKF = 1 was independently associated with improved OS (HR 0.77, 95%CI 0.61-0.97) and EFS (HR 0.72, 95%CI 0.58-0.90), and higher odds of achieving CR/CRi (OR 1.72, 95%CI 1.10-2.70) compared with NKF = 0. EFS was significantly associated with NKF categories in both classification systems (p <0.05). Conclusion: NKF is a novel, readily obtainable prognostic parameter derived from routine cytogenetics that independently predicts treatment response and survival in AML. External validation and prospective studies are warranted to support its use in clinical risk stratification frameworks.
- 19 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessThe Prognostic Utility of Normal Karyotype Fraction in Acute Myeloid Leukemia
Background: The prognostic significance of the proportion of normal metaphases detected at diagnosis in acute myeloid leukemia (AML) has not been systematically evaluated. Methods: We conducted a retrospective cohort study of 893 adult AML patients treated at Cleveland Clinic between 01/2015-09/2023 who underwent conventional cytogenetic analysis. Normal karyotype fraction (NKF) was defined as the proportion of normal metaphases among all metaphases analyzed at diagnosis. NKF was evaluated as a continuous measure and categorized using three-group (NKF = 0, 0 < NKF < 1, NKF = 1) and five-group functional classification systems. Primary outcomes included overall survival (OS), event-free survival (EFS), composite complete remission (CR/CRi), and relapse. Multivariable Cox proportional hazards and logistic regression models were adjusted for established prognostic covariates. Results: NKF demonstrated a bimodal distribution across the cohort. Patients with NKF = 1 achieved the highest CR/CRi rate (64%) and longest median OS (16 months) and EFS (11 months). In multivariable analyses, NKF = 1 was independently associated with improved OS (HR 0.77, 95%CI 0.61-0.97) and EFS (HR 0.72, 95%CI 0.58-0.90), and higher odds of achieving CR/CRi (OR 1.72, 95%CI 1.10-2.70) compared with NKF = 0. EFS was significantly associated with NKF categories in both classification systems (p <0.05). Conclusion: NKF is a novel, readily obtainable prognostic parameter derived from routine cytogenetics that independently predicts treatment response and survival in AML. External validation and prospective studies are warranted to support its use in clinical risk stratification frameworks.
- Open Access
- 16 January 2026
- Published by Wiley in Case Reports in Oncological Medicine
- Vol. 2026 (1)
When the Heart Is the Target: Case of Primary Pericardial Diffuse Large B‐Cell Lymphoma Presenting With Tamponade
Diffuse large B‐cell lymphoma (DLBCL) is an aggressive malignancy and the most common subtype of non‐Hodgkin lymphoma, typically presenting with lymphadenopathy. Pericardial involvement is extremely rare. We report the case of a patient who presented with cough and shortness of breath and was admitted for acute hypoxic respiratory failure. During hospitalization, the patient developed atrial fibrillation with rapid ventricular response (RVR). Transthoracic echocardiography revealed a pericardial effusion, which increased in size on repeat imaging 1 week later. The patient subsequently underwent pericardiocentesis, and cytology of the pericardial fluid confirmed DLBCL, with the pericardium identified as the primary site of involvement. The patient was treated with mini‐R‐CHOP chemotherapy, resulting in marked clinical improvement.
- 16 January 2026
- Published by Wiley in Case Reports in Oncological Medicine
- Vol. 2026 (1)
Open AccessWhen the Heart Is the Target: Case of Primary Pericardial Diffuse Large B‐Cell Lymphoma Presenting With Tamponade
Diffuse large B‐cell lymphoma (DLBCL) is an aggressive malignancy and the most common subtype of non‐Hodgkin lymphoma, typically presenting with lymphadenopathy. Pericardial involvement is extremely rare. We report the case of a patient who presented with cough and shortness of breath and was admitted for acute hypoxic respiratory failure. During hospitalization, the patient developed atrial fibrillation with rapid ventricular response (RVR). Transthoracic echocardiography revealed a pericardial effusion, which increased in size on repeat imaging 1 week later. The patient subsequently underwent pericardiocentesis, and cytology of the pericardial fluid confirmed DLBCL, with the pericardium identified as the primary site of involvement. The patient was treated with mini‐R‐CHOP chemotherapy, resulting in marked clinical improvement.